Lu Zhang

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Sandeep T. Patil, Lu Zhang, Ferenc Martényi et al. · Nature Medicine · 2007 · 1K citations

Medicine, Pharmacology, Psychiatry +12

History of winning remodels thalamo-PFC circuit to reinforce social dominance

Tingting Zhou, Hong Zhu, Zhengxiao Fan et al. · Science · 2017 · 368 citations

Life Sciences, Neurobiology, Neuroscience +17

A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia

Bruce J. Kinon, Lu Zhang, Brian A. Millen et al. · Journal of Clinical Psychopharmacology · 2011 · 257 citations

Medicine, Pharmacology, Psychiatry +17

Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia

Bruce J. Kinon, Brian A. Millen, Lu Zhang et al. · Biological Psychiatry · 2015 · 167 citations

Medicine, Pharmacology, Psychiatry +14

Neurons in the Amygdala with Response-Selectivity for Anxiety in Two Ethologically Based Tests

Dong V. Wang, Fang Wang, Jun Liu et al. · PLoS ONE · 2011 · 82 citations · Full text

Life Sciences, Neuroscience, Psychology +8